A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early animal testing.
Apr 16, 2021
0
171
Two different COVID vaccines are predicted to be protective against a rapidly spreading variant of the SARS-Cov-2 virus that arose in California, reports a Duke Health-led research team. However, the vaccines were found to ...
Apr 8, 2021
0
94
US manufacturer Moderna on Tuesday said it has started COVID-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
Mar 16, 2021
0
8
The European Union's drug regulator insisted Tuesday that there is "no indication" the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to ...
Mar 16, 2021
0
3
A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and ...
Mar 10, 2021
0
267
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease ...
Mar 2, 2021
0
7
US biotech firm Moderna said Wednesday that doses of its new COVID-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
Feb 24, 2021
0
5
The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.
Feb 19, 2021
0
13
French pharmaceutical startup Valneva had big news in September: a government contract for 60 million doses of its coronavirus vaccine candidate.
Feb 7, 2021
0
4
While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight ...
Jan 25, 2021
0
2
